検索
Tvardi Therapeutics Ord Shs
TVRDウォッチリストに追加
2.100USD
0.0000.00%
終値 07-31 16:00（ET）15分遅れの株価
26.23M時価総額
0.32直近12ヶ月PER
詳細情報 企業名
Tvardi Therapeutics Ord Shsの企業情報
企業コード- -
会社名- -
上場日- -
最高経営責任者「CEO」- -
従業員数- -
証券種類- -
決算期末- -
本社所在地- -
都市- -
証券取引所- -
国- -
郵便番号- -
電話番号- -
ウェブサイト- -
企業コード- -
上場日- -
最高経営責任者「CEO」- -
Tvardi Therapeutics Ord Shsの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Susan Shiff, Ph.D.
Dr. Susan Shiff, Ph.D.
Independent Director
Independent Director
5.61K
--
Mr. Sujal A. Shah
Mr. Sujal A. Shah
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Wallace Hall
Mr. Wallace Hall
Independent Director
Independent Director
--
--
Mr. Michael S. Wyzga
Mr. Michael S. Wyzga
Independent Director
Independent Director
--
--
Dr. Imran Alibhai, Ph.D.
Dr. Imran Alibhai, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Cynthia Smith
Ms. Cynthia Smith
Independent Director
Independent Director
--
--
Mr. Dan Conn, J.D.
Mr. Dan Conn, J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Dr. John Kauh, M.D.
Dr. John Kauh, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Jeffrey (Jeff) Larson, Ph.D.
Dr. Jeffrey (Jeff) Larson, Ph.D.
Senior Vice President - Research & Development
Senior Vice President - Research & Development
--
--
Dr. Yixin (Joseph) Chen, Ph.D.
Dr. Yixin (Joseph) Chen, Ph.D.
Vice President - Chemistry, Manufacturing and Controls
Vice President - Chemistry, Manufacturing and Controls
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Susan Shiff, Ph.D.
Dr. Susan Shiff, Ph.D.
Independent Director
Independent Director
5.61K
--
Mr. Sujal A. Shah
Mr. Sujal A. Shah
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Wallace Hall
Mr. Wallace Hall
Independent Director
Independent Director
--
--
Mr. Michael S. Wyzga
Mr. Michael S. Wyzga
Independent Director
Independent Director
--
--
Dr. Imran Alibhai, Ph.D.
Dr. Imran Alibhai, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Cynthia Smith
Ms. Cynthia Smith
Independent Director
Independent Director
--
--
よくある質問
Tvardi Therapeutics Ord Shsの上位5名の株主は誰ですか？
Tvardi Therapeutics Ord Shsの上位5名の株主は以下のとおりです。Dr. Susan Shiff, Ph.D.
Tvardi Therapeutics Ord Shsの最大の収益源は何ですか？
2026Q4において、Other revenue 部門がTvardi Therapeutics Ord Shsにとって最大の収益を生み出しており、その金額は1.32Mで、全収益の51.50%を占めています。